Sol Atriyal Apendikste Trombüs Gelişimi Risk Faktörleri

Watson T, Shantsila E, Lip GYH. Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet [Internet]. 2009;373(9658):155–66. Available from: http://dx.doi.org/10.1016/s0140-6736(09)60040-4

Masawa N, Yoshida Y, Yamada T, Joshita T, Ooneda G. Diagnosis of cardiac thrombosis in patients with atrial fi brillation in the absence of macroscopically visible thrombi. Virchows Arch A Pathol Anat Histopathol. 1993;422:67–71.

Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fi brillation. Circulation. 1997;96:1180–4.

Tziakas DN, Chalikias GK, Papanas N, Stakos DA, Chatzikyriakou SV, Maltezos E. Circulating levels of collagen type I degradation marker depend on the type of atrial fi brillation. Europace. 2007;9:589–96.

Marin F, Roldan V, Climent V, Garcia A, Marco P, Lip GY. Is thrombogenesis in atrial fi brillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1? Stroke. 2003;34:1181–6.

Li X, Ma C, Dong J. The fi brosis and atrial fi brillation: is the transforming growth factor-beta(1) a candidate etiology of atrial fi brillation. Med Hypotheses. 2008;70:317–9.

Goldsmith IR, Blann AD, Patel RL, Lip GY. Von Willebrand factor, fi brinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair. Am J Cardiol. 2000;85:1218–22.

Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fi brillation. The Stroke Prevention In Atrial Fibrillation Investigators committee on echocardiography. 1998;128:639–47.

Sanfi Lippo AJ, Abascal VM, Sheehan M. Atrial enlargement as a consequence of atrial fi brillation. A prospective echocardiographic study. Circulation. 1990;82:792–7.

Keren G, Etzion T, Sherez J. Atrial fi brillation and atrial enlargement in patients with mitral stenosis. Am Heart J. 1987;114:1146–55.

The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fi brillation: II Echocardiographic features of patients at risk. Ann Intern Med. 1992;116:6–12.

Tullio D, Sacco MR, Sciacca RL, Homma RR. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke. 1999;30:2019–24.

Salem DN, Stein PD, Ahmad A. Antithrombotic therapy in valvular heart disease-native and prosthetic: the seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:457-82S.

Ganesan AN, Chew DP, Hartshorne T, Selvanayagam JB, Aylward PE, Sanders P, et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur Heart J [Internet]. 2016;37(20):1591–602. Available from: http://dx.doi.org/10.1093/eurheartj/ehw007

Chiang C-E, Okumura K, Zhang S, Chao T-F, Siu C-W, Wei Lim T, et al. 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation. J Arrhythm [Internet]. 2017;33(4):345–67. Available from: http://dx.doi.org/10.1016/j.joa.2017.05.004

Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest [Internet]. 2018;154(5):1121–201. Available from: http://dx.doi.org/10.1016/j.chest.2018.07.040

January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American college of cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society in collaboration with the society of thoracic surgeons. Circulation [Internet]. 2019;140(2). Available from: http://dx.doi.org/10.1161/cir.0000000000000665

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J [Internet]. 2021;42(5):373–498. Available from: http://dx.doi.org/10.1093/eurheartj/ehaa612

Huang J, Wu SL, Xue YM, Fei HW, Lin QW, Ren SQ, et al. Association of CHADS2 and CHA2DS2-VASc scores with left atrial thrombus with nonvalvular atrial fibrillation: A single center based retrospective study in a cohort of 2695 Chinese subjects. Biomed Res Int [Internet]. 2017;2017:6839589. Available from: http://dx.doi.org/10.1155/2017/6839589

Lip GYH, NieuwSAAt R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest [Internet]. 2010;137(2):263–72. Available from: http://dx.doi.org/10.1378/chest.09-1584

Ozturk D, Celik O, Akin F. Usefulness of the uric acid and CHA2DS2-VASc score in prediction of left atriyal thrombosis in patients with mitral stenosis and sinus rhythm. Cardiol J. 2015;22(3):336–42.

Chao T-F, Nedeljkovic MA, Lip GYH, Potpara TS. Stroke prevention in atrial fibrillation: comparison of recent international guidelines. Eur Heart J Suppl [Internet]. 2020;22(Suppl O):O53–60. Available from: http://dx.doi.org/10.1093/eurheartj/suaa180

Mahajan R, Brooks AG, Sullivan T, Lim HS, Alasady M, Abed HS, et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart [Internet]. 2012;98(15):1120–6. Available from: http://dx.doi.org/10.1136/heartjnl-2012-301799

Stewart S, Hart CL, Hole DJ. A population-based study of the long-term risks associated with atrial fib- rillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113(5):359–64.

Liu Y, Zhu D, Xiao Y, Zhu Y, Zhou Q, Ren L, et al. Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation. Open Med (Warsz) [Internet]. 2021;16(1):361–6. Available from: http://dx.doi.org/10.1515/med-2021-0009

Kapłon-Cieślicka A, Budnik M, Gawałko M, Peller M, Gorczyca I, Michalska A, et al. Atrial fibrillation type and renal dysfunction as important predictors of left atrial thrombus. Heart [Internet]. 2019;105(17):1310–5. Available from: http://dx.doi.org/10.1136/heartjnl-2018-314492

Ba S. higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the rOcKet-aF trial. Eur Heart J. 2015;36:288–96.

Sikorska A, Baran J, Pilichowska-Paszkiet E, Sikora-Frąc M, Kryński T, Piotrowski R, et al. Risk of left atrial appendage thrombus in patients scheduled for ablation for atrial fibrillation: beyond the CHA2DS2VASc score. Pol Arch Med Wewn [Internet]. 2015;125(12):921–8. Available from: http://dx.doi.org/10.20452/pamw.3213

Ntaios G, Vemmou A, Koroboki E, Savvari P, Makaritsis K, Saliaris M, et al. The type of atrial fibrillation is associated with long-term outcome in patients with acute ischemic stroke. Int J Cardiol [Internet]. 2013;167(4):1519–23. Available from: http://dx.doi.org/10.1016/j.ijcard.2012.04.131

Batra GSvennblad B. all types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome. Heart. 2016;102:926–33.

Kim D, Yang P-S, Kim T-H, Jang E, Shin H, Kim HY, et al. Ideal blood pressure in patients with atrial fibrillation. J Am Coll Cardiol [Internet]. 2018;72(11):1233–45. Available from: http://dx.doi.org/10.1016/j.jacc.2018.05.076

Chao TF, Wang KL, Liu CJ, Lin YJ, Chang SL, Lo LW, et al. Age thresh- old for increased stroke risk among patients with atrial fibrillation: a Nationwide Cohort Study from Taiwan. J Am Coll Cardiol. 2015;66:1339–47.

Yilmaz KC, Akgun AN, Ciftci O, Eroglu S, Pirat B, Sade E, et al. Risk factors for left atrial appendage thrombus. Acta Cardiol [Internet]. 2020;75(4):355–9. Available from: http://dx.doi.org/10.1080/00015385.2020.1757852

Nielsen PB, Skjoth F, Overvad TF, Larsen TB, Lip G. Female sex is a risk modifier rather than a risk factor for stroke in atrial fibrilla- tion: should we use a CHA2DS2-VA score rather than CHA2DS2-VASc? Circulation. 2018;137:832–40.

Friberg L, Benson L, Rosenqvist M, Lip GY. Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospec- tive cohort study. BMJ. 2012;344.

Schaeffer B, Rüden L, Salzbrunn T, Pinnschmidt HO, Akbulak RÖ, Moser JM, et al. Incidence of intracardiac thrombus formation prior to electrical cardioversion in respect to the mode of oral anticoagulation. J Cardiovasc Electrophysiol [Internet]. 2018;29(4):537–47. Available from: http://dx.doi.org/10.1111/jce.13447

Al-Saady NM, Obel OA, Camm AJ. Left atrial appendage: structure, function, and role in thromboembolism. Heart [Internet]. 1999;82(5):547–54. Available from: http://dx.doi.org/10.1136/hrt.82.5.547